TCL Archive DePinho Apologizes For Investment Advice: On CNBC He Recommended A Firm He Founded June 1, 2012
TCL Archive In Brief: Thomas Davis Is Named New Director Of NCCP; Senate Subcommittee Give NCI $1.2 Bil. For FY ‘86 September 27, 1985
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
